Ekso Bionics Holdings, Inc.
EKSO
$4.69
-$0.04-0.85%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.23M | 2.06M | 3.38M | 5.09M | 4.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.23M | 2.06M | 3.38M | 5.09M | 4.13M |
| Cost of Revenue | 1.68M | 1.24M | 1.57M | 2.38M | 1.92M |
| Gross Profit | 2.55M | 819.00K | 1.81M | 2.71M | 2.21M |
| SG&A Expenses | 3.40M | 3.94M | 4.08M | 4.69M | 4.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.63M | 6.03M | 6.64M | 7.32M | 6.77M |
| Operating Income | -1.40M | -3.98M | -3.26M | -2.23M | -2.64M |
| Income Before Tax | -1.42M | -2.71M | -2.89M | -3.41M | -2.07M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.42M | -2.71M | -2.89M | -3.41M | -2.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.42M | -2.71M | -2.89M | -3.41M | -2.07M |
| EBIT | -1.40M | -3.98M | -3.26M | -2.23M | -2.64M |
| EBITDA | -1.04M | -3.60M | -2.88M | -1.83M | -2.23M |
| EPS Basic | -0.54 | -1.24 | -1.71 | -2.08 | -1.53 |
| Normalized Basic EPS | -0.34 | -0.78 | -1.00 | -1.30 | -0.96 |
| EPS Diluted | -0.54 | -1.24 | -1.71 | -2.08 | -1.53 |
| Normalized Diluted EPS | -0.34 | -0.78 | -1.00 | -1.30 | -0.96 |
| Average Basic Shares Outstanding | 2.62M | 2.18M | 1.69M | 1.64M | 1.35M |
| Average Diluted Shares Outstanding | 2.62M | 2.18M | 1.69M | 1.64M | 1.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |